JCR Pharmaceuticals Co., Ltd. (TYO:4552)

Japan flag Japan · Delayed Price · Currency is JPY
665.00
-6.00 (-0.89%)
Jul 22, 2025, 3:30 PM JST
4.56%
Market Cap81.02B
Revenue (ttm)33.07B
Net Income (ttm)-4.76B
Shares Out121.84M
EPS (ttm)-38.43
PE Ration/a
Forward PE28.82
Dividend20.00 (2.98%)
Ex-Dividend DateSep 29, 2025
Volume1,260,400
Average Volume2,035,300
Open679.00
Previous Close671.00
Day's Range661.00 - 679.00
52-Week Range386.00 - 765.00
Beta0.01
RSI72.41
Earnings DateJul 30, 2025

About JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The comp... [Read more]

Sector Healthcare
Founded 1975
Employees 987
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4552
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.